Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal

Clinical trial NCT03541356 · COMPLETED

Trial details

NCT number: NCT03541356
Sponsor: Impel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2018-05-08
Primary completion: 2019-06-11
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.